Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Karo Pharma AB's share price for the quarter that ended in Jun. 2022 was $5.71. Karo Pharma AB's Shares Outstanding (EOP) for the quarter that ended in Jun. 2022 was 273.3 Mil. Therefore, Karo Pharma AB's market cap for the quarter that ended in Jun. 2022 was $1,560.3 Mil.
Karo Pharma AB's quarterly market cap
stayed the same
from Sep. 2021 ($1,296.4 Mil) to Dec. 2021 ($1,296.4 Mil) but then
increased
from Dec. 2021 ($1,296.4 Mil) to Jun. 2022 ($1,560.3 Mil).
Karo Pharma AB's annual market cap
increased
from Dec. 2019 ($887.0 Mil) to Dec. 2020 ($1,406.8 Mil) but then
declined
from Dec. 2020 ($1,406.8 Mil) to Dec. 2021 ($1,296.4 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Karo Pharma AB's Enterprise Value for Today is $2,341.2 Mil.
Karo Pharma AB Market Cap Historical Data
The historical data trend for Karo Pharma AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Karo Pharma AB's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Karo Pharma AB's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Karo Pharma AB's Market Cap falls into.
Karo Pharma AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Karo Pharma AB's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Karo Pharma AB (OTCPK:KARBF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Karo Pharma AB Market Cap Related Terms
Thank you for viewing the detailed overview of Karo Pharma AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Karo Pharma AB (Karo Pharma AB) Business Description
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KARBF has been successfully added to your 